Local manufacturing

Expanded production capacity in local and regional hubs is critical to ensuring that healthcare providers in low- and middle-income countries can implement effective testing strategies to contain the spread of the virus. In an outbreak situation, RDTs need to be produced and distributed quickly in huge volumes, which requires manufacturing capacity to be in place before the outbreak begins. Unfortunately, prior to COVID-19, this was not the case, thus manufacturers found themselves rushing to fill a capacity gap.

Diagnostics and intellectual property

The pharmaceutical and vaccines industries both make regular use of patents to protect their innovative products. However, patents are less consequential for diagnostics. This document explains how intellectual property rights are protected in the diagnostics industry.